Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
Status:
Completed
Trial end date:
2019-06-27
Target enrollment:
Participant gender:
Summary
This pilot study examines the feasibility and acceptability of transitioning office-based
buprenorphine treatment of opioid use disorder from physicians to pharmacists. Results from
this study will inform the development of a future multi-site randomized clinical trial.
Phase:
Early Phase 1
Details
Lead Sponsor:
Duke University
Collaborators:
National Institute on Drug Abuse (NIDA) The Emmes Company, LLC The EMMES Corporation
Treatments:
Analgesics, Opioid Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone